Parabens are commonly used in cosmetics and personal care products to protect against microbial growth, but a new study suggests that manufacturers may also be using parabens in plastic teething products designed for infants. Scientists applied an effect-directed approach (to determine endocrine disrupting ability) to analyze teething products prior to chemical analysis using gas chromatography coupled to mass spectrometry (GC–MS). Of 10 products were tested, two were found to contain endocrine disrupting chemicals (EDCs).
Photo Credit: RUTH JENKINSON/SPL/Getty Images
Parabens are commonly used in cosmetics and personal care products to protect against microbial growth, but a new study published in the Journal of Applied Toxicology suggests that manufacturers may also be using parabens in plastic teething products designed for infants.1 Scientists applied an effect-directed approach (to determine endocrine disrupting ability) to analyze teething products prior to chemical analysis using gas chromatography coupled to mass spectrometry (GC–MS). Of 10 products were tested, two were found to contain endocrine disrupting chemicals (EDCs).
EDCs are natural or synthetic compounds that disrupt the normal functioning of the human endocrine system, often imitating natural hormones, and are recognized as a contributing factor to a range of diseases. In light of this, the use of phthalates in toys is restricted in the European Union to reduce childhood exposure. However, there is a huge variety of possible EDCs used in plastics, meaning that exposure is likely to be underestimated because analysis focuses on common culprits such as Bisphenol A and phthalates. Corresponding author Martin Wagner from Goethe University Frankfurt am Main, Germany, told The Column: “Our research is about the EDCs we do not know yet: Instead of analyzing well known compounds, we use in vitro bioassays to screen all types of samples for hormonal activity and try to identify the causative chemicals using non-target chemical analysis afterwards (effect-directed analysis).” He added: “In that sense, our research demonstrates that there are far more EDCs out there (which we currently overlook) and that they come from unexpected sources (who would have suspected a plastic to contain parabens).”
Samples were taken from 10 plastic and one natural rubber teething soothers purchased in Germany in 2012. Methanol extracts and water eluates from the samples were screened using a Yeast Estrogen Screen (YES) and a Yeast Antiandrogen Screen (YAAS). One sample was shown to possess both estrogenic and antiandrogenic activity, and another was found to be antiandrogenic. GC–MS analysis showed the presence of ethyl-, methyl-, and propylparaben in one product. Wagner told The Column: “In [the] case of one product we found three different parabens. These are well-known EDCs, which are normally used as preservatives in cosmetics.” He added: “In [the] case of the second product, we demonstrated that this teether leached six different EDCs, all of which remain so far unidentified. In a broader sense, our study demonstrates that babies will be exposed to EDCs when chewing on plastic teethers. Because they are especially susceptible, we should aim at minimizing their exposure to EDCs.” - B.D.
Reference
1. E. Berger et al., Journal of Applied Toxicology DOI 10.1002/jat.3159 (2015).
This story was featured in LCGC's digital magazine, The Column. Click here to view the full issue>>
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.